Opt Health Vs Fountain Life

Opt Health and Fountain Life both bundle a physician and a treatment pathway, and there the resemblance ends. Fountain Life adds full-body MRI, coronary CT, DEXA, a 200+ marker panel, and in-person clinical days, at $19,500+ a year. Opt Health runs 55+ markers through a telehealth loop at roughly $3,000. One platform is organized around imaging you cannot get from blood; the other around a treatment cycle you can run from home. The gap between them is about $16,500 a year.

Public litigation

Fountain Life Holdings faces an open New York suit filed by a physician (July 2023) alleging fraud and deceptive practices over a clinic arrangement. Allegations only — Westfair Online.

What each platform actually is

Opt Health

Opt Health is a telehealth membership at roughly $3,000 a year. It covers a 55+ biomarker panel across hormones, metabolic markers, inflammation, nutrients, and liver, kidney and blood counts; a one-on-one consult with a physician; a protocol built from those results; and a repeat of the same panel every 3–4 months with the protocol adjusted against it. Phlebotomy comes to the member at home in most markets. A care team handles questions between consults through the app. TRT, peptides, GLP-1 medications and supplement protocols are prescribed where the labs support them and billed at medication cost. Opt Health runs no imaging of any kind, performs no physical examination, and bills no insurance.

Fountain Life

Fountain Life sells the APEX membership at $19,500+ a year. It covers a full-body MRI, a coronary CT with calcium scoring, DEXA body composition, a 200+ biomarker panel, and in-person clinical days at a Fountain Life location — Naples, Dallas, and expanding sites. A care team stays reachable between visits, with quarterly touchpoints, and a full prescription pathway covers TRT, peptides and GLP-1s. Travel to the clinic is not included and runs $1,500–$2,500 per visit. Advanced screening add-ons such as Galleri and expanded genomics cost $500–$2,000 each. Fountain Life bills no insurance, though HSA and FSA funds can cover portions.

Side by side on the standard rubric

The same nine criteria for both columns. Two of the rows — draw type and hidden costs — carry more weight here than on any other comparison in this category.

What each actually costs

Opt Health has one price and one variable. The ~$3,000 membership contains physician time, the panel, and every 3–4 month re-run, and no part of it meters per use. No one-time onboarding fee is stated, so a second year costs what the first did and a two-year commitment lands near $6,000 in membership. Medication is the only line that moves: TRT adds roughly $600–$2,400 across twelve months, a compounded GLP-1 roughly $2,400–$4,800, peptides roughly $1,800–$4,800. That is the whole distance between the $3,000 floor and the $6,000-plus published ceiling.

Fountain Life has one price and three variables. The $19,500+ membership covers the imaging, the 200+ panel, and the clinical days. Travel adds $1,500–$2,500 per visit and appears on no pricing page. Advanced screening add-ons run $500–$2,000 each, and prescribed therapies are billed at their own cost — which is why the platform's realistic year-one range is $22,000–$30,000+ rather than the headline figure. No one-time onboarding fee is stated here either, so year two tracks year one: roughly $19,500 plus whatever travel and add-ons you repeat, putting two years near $39,000 in membership alone.

Where Opt Health leads

• Price band. ~$3,000 a year against $19,500+, a difference of roughly $16,500 annually and about $33,000 across two years of membership.
• Flat cost structure. One annual fee with medication as the only variable — no travel line, no per-visit charge, and no menu of screening add-ons priced separately.
• No travel or clinic scheduling. Consults run over telehealth, so a reassessment costs an hour rather than a 2–3 day trip.
• At-home phlebotomy in most markets. The draw comes to the member instead of requiring a clinic day to collect blood.
• Smaller sum committed to test the fit. A full year of Opt Health costs about what a Fountain Life member may spend on travel plus a single advanced screening add-on.

Where Fountain Life leads

• Full-body MRI. Screens for structural findings — tumours, aneurysms, nodules — that no blood panel at any price detects.
• Coronary CT with calcium scoring. Measures plaque that already exists, where markers like ApoB and Lp(a) estimate the risk of developing it.
• DEXA body composition. Direct measurement of lean mass, fat mass and bone density on site, rather than inference from weight and blood markers.
• In-person clinical days. Physical examination and same-day clinician time at a Fountain Life location, with results discussed face to face.
• Panel breadth. 200+ biomarkers against 55+, with expanded genomics and multi-cancer screening available as add-ons.

Trade-offs to weigh

Opt Health trade-offs

• No imaging at any tier. Blood markers cannot find a renal mass, an aortic aneurysm, or existing coronary plaque. ApoB and Lp(a) describe cardiovascular risk; they do not measure what is already in the artery.
• Panel is roughly a quarter the size. 55+ against 200+, with genomics and multi-cancer screening outside the product entirely — they cannot be purchased as add-ons the way they can at the other platform.
• No physical examination. Nobody palpates a thyroid or a testis, takes a blood pressure in person, or looks at your skin. Findings that surface on a routine hands-on exam fall outside the model.
• Cash-pay, with medication on top and a market caveat on draws. No insurance channel, HSA/FSA subject to your administrator, prescriptions billed at cost, and at-home phlebotomy available in most markets rather than all of them.

Fountain Life trade-offs

• Entry price and realistic total. $19,500+ to start and $22,000–$30,000+ in a realistic first year — roughly six to seven times the Opt Health membership before either platform prescribes anything.
• Travel is required and unpriced. The clinical days happen in person at Naples, Dallas, and expanding locations. A 2–3 day trip runs $1,500–$2,500 per visit, and none of it appears on the pricing page.
• Add-on menu on top of a five-figure fee. Galleri and expanded genomics run $500–$2,000 each, and hormone and peptide therapies are billed separately, so the membership is a base rather than a ceiling.
• Screening findings carry their own downstream cost. Whole-body MRI on asymptomatic adults regularly turns up incidental findings that are usually benign but cannot be resolved from the image. The follow-up scans, specialist referrals and occasional biopsies are outside the membership.

Who should pick each

Pick Opt Health if: you are over 40, the thing you want changed is a set of biomarkers — testosterone, fasting insulin, ApoB, thyroid, inflammation — and you want a physician adjusting a protocol against them every few months. You want the panel drawn at home, the consults over video, and the annual cost inside $3,000–$6,000. You have no specific structural question that would require a scan to answer.

Pick Fountain Life if: you have a structural question — family history of aneurysm, early cardiac death, or a specific cancer — and you want it answered with imaging rather than inferred from blood. You can absorb $22,000–$30,000 in year one, you live near Naples or Dallas or will travel there, and you want a physical exam and a face-to-face review of the scans on the same clinical day.

Who should pick neither

A membership bundles screening with an ongoing relationship. Plenty of people want only one of the two, and buying the bundle to get half of it is where most of the money is wasted in this category. Four alternatives cover those cases.

• You want the scan, not the program. Ezra and Prenuvo both sell whole-body MRI standalone, without an annual membership attached.
• Cancer screening is the specific worry. Galleri is a multi-cancer blood test sold on its own, and it answers a narrower question at a far smaller cost than a concierge year.
• You want data without a prescriber. Function Health runs a wide panel with no treatment relationship attached, for a fraction of either membership here.
• Your question is cardiovascular and you have insurance. A coronary calcium score is widely available as a standalone cash-pay scan and through cardiology referral, and an in-network lipid and ApoB workup costs a copay. That combination answers most of the heart question directly.

Can you use both?

Together the memberships run about $22,500 a year, and $25,000–$36,000 all-in once travel, add-ons and medication are counted. The duplication is heavy. Fountain Life's 200+ panel contains most of what Opt Health's 55+ panel measures, both include a physician, both include a care team between contacts, and both write the same categories of prescription. Paying twice for the second copy of a hormone panel, and asking two clinicians to titrate from it, produces conflicting protocols rather than a more thorough one.

The one arrangement that holds up is not really stacking: buy the imaging once and the loop annually. A single Fountain Life year for the scans and baseline, then a lower-priced telehealth program for the ongoing protocol work, gets the structural answers without committing $19,500 every year for information that does not change annually for most people. If you do run both simultaneously, name one prescriber as the owner of hormone and metabolic decisions, and send each side the other's most recent panel.

What the rubric does not capture

The table cannot show what an out-of-range result triggers. At Fountain Life, an abnormal finding on a clinical day can be escalated in the building — another scan, another opinion, a physical exam the same afternoon. At Opt Health, the equivalent event is a video call and a repeat draw, which is slower for anything structural but faster for anything that needs no imaging, because it needs no flight. The rubric row says "physician access" for both. What it costs you in hours to reach that physician is completely different.

Geography changes the value of each product more than any row suggests. A Fountain Life member who lives an hour from a clinic gets a different membership from one who flies twice a year — the second is paying a five-figure fee for a relationship that is telehealth for most of the calendar. An Opt Health member in a market without at-home phlebotomy loses the convenience that distinguishes the platform and arranges their own draw. Neither disadvantage is visible until you check your own postcode against the delivery model.

The two products are designed around different events, and that shows by month six. Fountain Life is built around an annual clinical day: the largest share of what you paid for is consumed early, and the rest of the year is follow-up. Opt Health is built around a repeating loop, so month six looks much like month one, with another panel and another adjustment. That shapes the cancellation risk on each side — leaving Fountain Life after the imaging means paying for a screening you already received, while leaving Opt Health mid-protocol ends the monitoring attached to an active TRT or GLP-1 prescription. One further caveat sits under all of this: the case for whole-body screening is strongest for someone with a documented family history of aortic disease, early cardiac death, or a specific hereditary cancer. For an asymptomatic adult without that history, incidental findings are the more likely outcome than a life-saving catch, and each one carries follow-up cost the membership does not cover.

Related

• Full Opt Health review
• Full Fountain Life review
• Fountain Life cost breakdown
• Opt Health cost breakdown
• All doctor-led options compared